Pharmaceutical companies have more reasons than ever to hone their launch readiness skills. The question is whether they possess the new product launch strategies and tools to successfully commercialise their new medicines in an often volatile and always competitive global marketplace.  

As we inch warily or rush enthusiastically into another year against a backdrop of political turmoil and business uncertainty in major markets, it is time to look at the prevailing 2019 pharmaceutical industry trends and what they might mean for companies launching new medicines, negotiating market access barriers, or simply trying to do what they do better. Inevitably, the US is in the thick of the action. But there are many other important 2019 pharma trends, both national and global, that will set the pace for industry throughout what promises to be another dynamic and challenging year. 

At TRiBECA® Knowledge we are proud to continue to support this highly unusual school with our 2018 Christmas donation.

From everyone here at TRiBECA® Knowledge, we wish you a very Merry Christmas and a Happy New Year! This holiday season TRiBECA® Knowledge’s international team would like to share some of our favourite Christmas food and drink recipes. We hope you try out a few and offer your Christmas table some new delights to make this holiday a bit different!

Tender management is fast entering the mainstream of pharmaceutical industry strategies. Getting the tendering process right, and making sure your global and local resources are properly aligned towards that goal, will make all the difference between riding this trend to a broader, more flexible revenue base, and watching competitors reap the benefits. The growing reliance on tenders as a cost-effective purchasing strategy for medicines in developing and developed countries creates a whole new set of market access challenges for the pharmaceutical industry.